X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
1. 6 Alpha-methylprednisolone Sodium Hemisuccinate
2. A-methapred
3. Hemisuccinate, Methylprednisolone
4. Methylprednisolone Hemisuccinate
5. Methylprednisolone Hemisuccinate Monosodium Salt
6. Methylprednisolone Sodium Hemisuccinate
7. Methylprednisolone Sodium Succinate
8. Methylprednisolone Succinate
9. Sodium Hemisuccinate, Methylprednisolone
10. Sodium Succinate, Methylprednisolone
11. Solumedrol
12. Succinate, Methylprednisolone
13. Urbason-soluble
14. Urbasonsoluble
1. Solu-medrone
2. Urbason Solubile
3. M-6-p
4. Nsc-48989
5. Methylprednisolone Sodium Hemisuccinate
6. U 9088
7. Urabason
8. 2375-03-3
9. Nsc48989
10. Prednisolone, Succinate, Sodium Salt
11. 6.alpha.-methylprednisolone Sodium Succinate
12. 6.alpha.-methylprednisolone 21-sodium Succinate
13. 6.alpha.-methylprednisolone Sodium Hemisuccinate
14. 6.alpha.-methylpregnisolone 21-sodium Succinate
15. 6.alpha.-methylprednisolone 21-sodium Hemisuccinate
16. 6.alpha.-methylprednisolone 21-hemisuccinate Sodium Salt
17. Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-, 21-(hydrogen Succinate), Monosodium Salt
18. Pregna-1,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, Monosodium Salt, (6.alpha.,11.beta.)-
| Molecular Weight | 497.5 g/mol |
|---|---|
| Molecular Formula | C26H34NaO8+ |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 7 |
| Exact Mass | 497.21513732 g/mol |
| Monoisotopic Mass | 497.21513732 g/mol |
| Topological Polar Surface Area | 138 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 1 |
| Complexity | 981 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Methylprednisolone sodium succinate |
| Drug Label | SOLU-MEDROL Sterile Powder is an antiflammatory glucocorticoid, which contains methylprednisolone sodium succinate as the active ingredient. Methylprednisolone sodium succinate, USP, is the sodium succinate ester of methylprednisolone, and it occurs... |
| Active Ingredient | Methylprednisolone sodium succinate |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 2gm base/vial; eq 40mg base/vial; eq 125mg base/vial; eq 500mg base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | Mustafa Nevsat; Fresenius Kabi Usa |
| 2 of 2 | |
|---|---|
| Drug Name | Methylprednisolone sodium succinate |
| Drug Label | SOLU-MEDROL Sterile Powder is an antiflammatory glucocorticoid, which contains methylprednisolone sodium succinate as the active ingredient. Methylprednisolone sodium succinate, USP, is the sodium succinate ester of methylprednisolone, and it occurs... |
| Active Ingredient | Methylprednisolone sodium succinate |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 2gm base/vial; eq 40mg base/vial; eq 125mg base/vial; eq 500mg base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | Mustafa Nevsat; Fresenius Kabi Usa |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
Antineoplastic Agents, Hormonal
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)
Glucocorticoids
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)
Neuroprotective Agents
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)
Market Place
